Skip to content

Effect of weak peripheral magnetic stimulation

Effect of weak peripheral magnetic stimulation to human body - WPMSH

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042200013
Enrollment
300
Registered
2020-05-29
Start date
2020-07-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with functional impairments and normal subjects

Interventions

Magnetic stimulation, electrical stimulation, and/or vibration were given 5-60 min for 1 time with duration from 1 day to 12 weeks in patients with functional impairments and in normal subjects. Elect

Sponsors

Otaka Yohei
Lead Sponsor
Maeda Hirofumi
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients whom electrical stimuilation and/or vibration therapy are indicated for rehabilitation and normal subject

Exclusion criteria

Exclusion criteria: Unstable condition and/or patients who used cardiac pacemaker or used unremovable magnetic material near the stimulation site

Design outcomes

Primary

MeasureTime frame
Effect of weak magnetic stimulation compared to electrical stimulation and/or vibration.

Secondary

MeasureTime frame
Electromyography, spasticity measured by tester for joint motion and Modified Ashworth Scale (MAS), presence or absence of clonus, muscle force, gait, pain, swallowing function, writing function, urination, excitability of cortical motor cortex, 3D motion analysis, and frequency of use of magnetic stimulator at home and the reasons

Contacts

Public ContactHirofumi Maeda

Fujita Health University Hospital

isaac_g_nw@yahoo.co.jp+81-562-93-2167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026